Despite the availability of new therapies, patients with pulmonary hypertension still face significant diagnostic delays and substantial emotional and financial burdens.
This study reports the largest UK survey exploring issues affecting patients with PH. The study shows that despite the availability of new therapies, patients are still experiencing delays prior to diagnosis, and experiencing both emotional and financial impacts from the disease. By identifying the areas patients find most important in their treatment, this research can inform future care policies and long-term management to support patients living with PH and their families.
Armstrong et al. (Thu,) studied this question.